Initial Keytruda showed consistent antitumor activity and safety in patients with advanced bladder cancer ineligible for ...

Discover how kidney function decline in ATTR-CM patients predicts higher mortality, highlighting its role as a critical marker in disease management and care optimisation.

Chronic kidney disease is one of the most common diseases in the world ... they should be eaten in moderation as eating these can lead to certain side effects as explained by the expert: People on ...

The field of microphysiological systems has continued to evolve during the past 20 years, doing so in response to the tremendous challenges ...

Prolonged use of renin-angiotensin system (RAS) inhibitors, common in hypertension treatment, can harm kidneys, leading to ...

New patents position Biomerica to address multi-billion-dollar markets in Europe, including GERD ($4 billion+), Crohn’s Disease ($2.5 billion+), ...

The risk for emergently treated hypocalcemia in individuals receiving denosumab peaked at 2 weeks after administration and ...

Hamoud, a heart failure consultant, revealed that approximately 80,000 people in Kuwait suffer from heart failure, with ...

For the first time, researchers have discovered that the accumulation of aged and failing cells, called senescent cells, in ...

The standard treatment for head and neck cancer, cisplatin, can’t be given to some patients due to pre-existing conditions. A new study compares the efficacy of two alternatives: cetuximab, a ...

Newcells kidney tissue models include a kidney toxicity service that investigates kidney toxicity and drug safety evaluation.

The Food and Drug Administration (FDA) has added a new boxed warning on the denosumab drug label (brand name: Prolia) to alert clinicians to an increased risk for severe hypocalcemia in patients with ...